Mark Nanes MD/PhD
Overview
Dr. Mark Nanes is professor of medicine at Emory University. Dr. Nanes received a BA at Clark University and PhD, MD at Case Western Reserve University in Cleveland. His graduate work in reproductive endocrinology focused on prolactin regulation of corpus luteum function in the laboratory of Dr. Irving Rothchild and later the study of extra renal production of vitamin D 1-alpha hydroxylase in decidual tissue and placenta. Dr. Nanes completed his internal medicine residency at University Hospitals, Case Western Reserve University. Following residency, Dr. Nanes trained in Endocrinology as a medical staff fellow in the Metabolic Diseases Branch at the National Institutes of Health. He worked with Dr. Stephen Marx and developed an interest in the pathophysiology of inflammatory cytokines in skeletal disorders.
Dr. Nanes joined the faculty at Emory University in 1988. He was program director of the Emory Endocrinology Fellowship Training Program. At the VA Medical Center, Dr. Nanes served as chief of the Endocrine Section and assistant chief of Subspecialty Medicine prior to his appointment as Chief of Medicine. Dr. Nanes stepped down from his position as Chief of Medicine at the VA in 2016.
Dr. Nanes has served as a member of the NIH Skeletal Biology Structure and Regeneration Study Section and the Department of Veterans Affairs Merit Review Board in Endocrinology. He is a past editorial board member for Endocrinology and the Journal of Bone and Mineral Research and is an ad hoc reviewer for a variety of endocrinology and bone journals. Dr. Nanes research focuses on the inflammatory cytokine TNF as a mediator of skeletal disease. TNF contributes to bone loss by targeting the differentiation, function, and lifespan of bone cells and by causing acquired resistance to vitamin D. His most recent projects evaluate cytokine modulation of signal pathways in bone cell differentiation and function. As Chief of Specialty Medicine at the VA Medical Center, Dr. Nanes faces the challenge of delivering quality care to a burgeoning patient population, the expansion of subspecialty services, enhancement of the Emory Medical residency program, and establishing a new VA dual affiliation with both Emory and Morehouse Schools of Medicine.
Academic Appointment
- Professor of Medicine, Emory University School of Medicine
- Assistant Professor of Medicine, Emory University School of Medicine
Education
Degrees
- MD from Case Western Reserve University
- AB from Clark University
- PhD from Case Western Reserve University
Research
Publications
-
Disseminated Cryptococcosis in An Immunocompetent Host Presenting As Osteomyelitis and Leading to Adrenal Insufficiency.
Am J Med Sci Volume: 363 Page(s): 75 - 79
01/01/2022 Authors: Hsu E; Webster SM; Nanes M -
Advances in treatment of glucocorticoid-induced osteoporosis.
Curr Opin Endocrinol Diabetes Obes Volume: 24 Page(s): 411 - 417
12/01/2017 Authors: Hsu E; Nanes M -
From Vascular Access to Adrenal Axis: Pre-endoscopic Management of MEN-2B Syndrome
Volume: 112 Page(s): S983 - S983
10/01/2017 Authors: Van Leer-Greenberg B; Haydek JP; Berger S; Goebel S; Nanes M -
Systolic Blood Pressure Control Among Individuals With Type 2 Diabetes: A Comparative Effectiveness Analysis of Three Interventions.
Am J Hypertens Volume: 28 Page(s): 995 - 1009
08/01/2015 Authors: Espeland MA; Probstfield J; Hire D; Redmon JB; Evans GW; Coday M; Lewis CE; Johnson KC; Wilmoth S; Bahnson J -
Progesterone and Src family inhibitor PP1 synergistically inhibit cell migration and invasion of human basal phenotype breast cancer cells.
Biomed Res Int Volume: 2015 Page(s): 426429
01/01/2015 Authors: Xie M; Zhou L; Chen X; Gainey LO; Xiao J; Nanes MS; Hou A; You S; Chen Q -
Osteocyte differentiation is delayed by low dose TNF.
Volume: 29 Page(s): S433 - S433
02/01/2014 Authors: Nanes M; Gilbert L -
Osteoporosis.
Semin Nucl Med Volume: 44 Page(s): 439 - 450
01/01/2014 Authors: Nanes MS; Kallen CB -
Phosphate wasting and fibroblast growth factor-23.
Curr Opin Endocrinol Diabetes Obes Volume: 20 Page(s): 523 - 531
12/01/2013 Authors: Nanes MS -
Chronic low dose tumor necrosis factor- (TNF) suppresses early bone accrual in young mice by inhibiting osteoblasts without affecting osteoclasts.
Bone Volume: 56 Page(s): 174 - 183
09/01/2013 Authors: Gilbert LC; Chen H; Lu X; Nanes MS -
Prx-1 Coverts MAPK Regulation of Osterix Transcription from Stimulation to Inhibition
Volume: 28
02/01/2013 Authors: Gilbert L; Nanes M